AIDS
- ORKIN C, Antinori A, Rockstroh JK, Moreno-Guillen S, et al
Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based
therapy: 96-week pooled analysis.
AIDS. 2024 Feb 12. doi: 10.1097/QAD.0000000000003865.
AIDS Res Hum Retroviruses
- LEE EH, Lee JA, Kim CH, Lee KH, et al
Pentraxin 3 as an immune recovery marker in HIV infection after combination
antiretroviral therapy.
AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0002.
- DU R, Huang J
Machine learning revealed a novel ferroptosis-based classification for diagnosis
in antiretroviral therapy-treated HIV patients with defective immune recovery.
AIDS Res Hum Retroviruses. 2023 Apr 8. doi: 10.1089/AID.2022.0138.
Clin Infect Dis
- SLAMA L, Barrett BW, Abraham AG, Palella FJ Jr, et al
Incident Proteinuria differs by HIV Serostatus among Men with Pre-diabetes: The
Multicenter AIDS Cohort Study.
Clin Infect Dis. 2024 Feb 9:ciae065. doi: 10.1093.
J Acquir Immune Defic Syndr
- DE WIT S, Bonnet F, Osiyemi O, Bisshop F, et al
Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide-Based
Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through
Week 196.
J Acquir Immune Defic Syndr. 2024 Feb 8. doi: 10.1097/QAI.0000000000003395.
JAMA
- ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
Delivery Device Patents on GLP-1 Receptor Agonists.
JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
Pediatr Infect Dis J
- KENNEALLY AM, Bates BN
Accidental Raltegravir Overdose in a Neonate: Case Report and Review of
Literature.
Pediatr Infect Dis J. 2024 Feb 6. doi: 10.1097/INF.0000000000004273.
PLoS One
- WU L, Wang Q, Gao QC, Shi GX, et al
Potential mechanisms and drug prediction of Rheumatoid Arthritis and primary
Sjogren's Syndrome: A public databases-based study.
PLoS One. 2024;19:e0298447.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016